Skip to content

Diagnostic Value of Ultrasonography in Pediatric Neurofibromatosis Type 1

Diagnostic Value of Ultrasonography in Pediatric Neurofibromatosis Type 1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115789
Enrollment
Unknown
Registered
2025-12-31
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatosis type 1

Interventions

Gold Standard:Concurrent MRI findings

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age 0–18 years, meeting the 2021 International Diagnostic Criteria for NF1; 2. Complete ultrasound examination and clinical data; 3. Complete and traceable case records.

Exclusion criteria

Exclusion criteria: 1.Complicated with other hereditary diseases (e.g., Noonan syndrome, Legius syndrome) or malignant tumors (e.g., rhabdomyosarcoma); 2.Previous surgical resection of critical lesions may affect the baseline data for ultrasonic assessment. 3.Substandard ultrasonic image quality (e.g., failure to clearly display the target area due to obstruction by obesity or severe intestinal gas); 4.Severe dysfunction of heart, liver, kidney and other organs;

Design outcomes

Primary

MeasureTime frame
Ultrasonic Characteristics of Neurofibromatosis Type 1;Database extraction: Demographic data, clinical characteristics, ultrasound parameters, MRI findings, and follow-up outcomes;Consistency Kappa value;

Countries

China

Contacts

Public ContactLuo Hongxia

The Second Affiliated Hospital of Wenzhou Medical University

luohongxia0127@163.com+86 10 12345678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026